Pharmacologic treatments for covid-19 patients

Budesonide vs Standard care


Outpatients

Forest plots
(last update: 2022-04-29)

Summary of findings
(last update: 2021-10-08)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=245

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
N/A
Alsultan M, Interdiscip Perspect Infect Dis, 2021
Full text
Commentary
Not reported/unclear

Colchicine

Budesonide

Colchicine

Standard care

Standard care

Budesonide

RCT Patients with suspected or confirmed COVID-19 (moderate-severe) admitted to a single center in Syria. N=49 N/A

Full description

ISRCTN86534580; EudraCT 2020-001209-22
PRINCIPLE
Yu LM, Lancet, 2021
Full text
Full text
Commentary
Commentary
Commentary
Public/non profit

Budesonide

Standard care

RCT Outpatients with suspected or confirmed COVID-19 (symptomatic-mild) treated by multiple centers in the UK N=1073
Some concerns
Details

Full description

NCT04416399
STOIC
Ramakrishnan S, Lancet Respir Med, 2021
Full text
Commentary
Commentary
Mixed

Budesonide

Standard care

RCT Outpatients with suspected or confirmed COVID-19 (mild) treated by a single center in the UK N=146 N/A

Full description